Scholars Central

Research articlePublished 3 May 2019

Evaluation of thiazolidinedione derivatives for acute toxicity and potential antidiabetic activity

Authors: Sushil D. Patil, Shital L. Nawale, V. Balasubramaniyan

Der Pharma Chemica

Volume 7 · Issue 5 · Pages 216–223

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The new TZD derivatives prepared (i.e. A1, A2, A5, B2, C1 and D1) were screened in vivo for acute oral toxicity study for the doses of 30 and 100 mg/kg in Wistar rats and were found to be safe as they did not show any treatment related adverse effects. So these six derivatives were evaluated for antidiabetic activity using the experimental model of diabetes induced by alloxan in rats for acute as well as subacute study.The results of the study revealed that most of the compounds tested showed moderate to good antidiabetic activity. The compound C1 was found to be the most active in all synthesized compounds which have nearly similar glucose lowering activity as that of standard drugs i.e. metformin and pioglitazone at dose of 100 mg/kg of body weight.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Der Pharma Chemica.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharma Chemica
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sushil D. Patil”
  • BylineArticles whose byline prints “Shital L. Nawale”
  • BylineArticles whose byline prints “V. Balasubramaniyan”